Ordre du Jour Commission spécialisée des Médicaments Anti-Infectieux, Vaccins et Sérums du 29/11/2023
N° | Date de Dépôt | PRODUIT | DCI | DOSAGE | FORME | Présentation | LABORATOIRE | MOTIF |
1 | 10/09/2019 | HEXAXIM | VACCIN D+T+C+P+HB+HIB | Suspension injectable | B/1seringue pré-remplie/0.5ml | SANOFI PASTEUR SA | INDICATIONS | |
2 | 17/09/2020 | CLAVOR XR | AMOXICILLINE+ACIDE CLAVULANIQUE | 1000/62,5 | cp pelliculé | B/40 | SAIPH-TUNISIE | AMM |
3 | 17/09/2020 | LEVOREC | LEVOFLOXACINE | 750mg | CP | B/10 | OPALIA PHARMA-TUNISIE | AMM |
4 | 17/09/2020 | TAVANIC | LEVOFLOXACINE | 5 mg/100 | SOLUTION INJECTABLE | B/1FL/100 ML | SANOFI-FRANCE | Extension des Indications |
5 | 17/09/2020 | TAVANIC | LEVOFLOXACINE | 500 mg | CP | B/10 | SANOFI-FRANCE | Extension des Indications |
6 | 17/09/2020 | TAVANIC | LEVOFLOXACINE | 500 mg | CP | B/05 | SANOFI-FRANCE | Extension des Indications |
7 | 16/10/2020 | SIFLOKS | Ciprofloxacine | 500 MG | CP | B/14 | TERIAK-TUNISIE | Extension des Indications |
8 | 16/10/2020 | SIFLOKS | Ciprofloxacine | 500 mg | CP | B/28 | TERIAK-TUNISIE | Extension des Indications |
9 | 16/10/2020 | SIFLOKS | Ciprofloxacine | 500 MG | CP | B/14 | TERIAK-TUNISIE | Extension des Indications |
10 | 20/10/2020 | LEVOCINE | LEVOFLOXACINE | 750 MG | CP | B/5 | DAR ESSAYDALI-TUNISIE | AMM |
11 | 25/11/2020 | AZITHROCINE 250 gélule B/6 | AZITHROMYCINE | 250 mg | gélule | SIPHAT | Indications | |
12 | 29/03/2021 | BAXDELA | Délafloxacine méglumine | 450 MG | Comprimé | B/20 | HIKMA- Jordan | AMM |
13 | 29/03/2021 | BAXDELA | Délafloxacine méglumine | 300 MG | Poudre pour solution pour perfusion | B/10FL/20ML | HIKMA- Jordan | AMM |
14 | 22/12/2020 | BOOSTRIX | VACCIN D+T+C | Suspension injectable | B/1seringue pré-remplie/0.5ml | Glaxo Smith KLine Biologicals | INDICATIONS | |
15 | 18/01/2021 | Cystodose | fodfomycine | 3 gr | Gr P Sol Buv | B/04 Sachets | SAIPH-TUNISIE | Extension des Indications |
16 | 20/01/2021 | Monuril | fosfomycine | 3 g | granulé pour solution buvable | Zambon | Indication | |
17 | 10/03/2021 | ABHAY-TAG | VACCIN ADSORBE DIPHTERIQUE TETANIQUE ET COQUELUCHEUX B.P | Suspension stérile pour inject | B/10Fl/5ml | HUMAN BILOGICALS INSTITUTE INDE | AMM | |
18 | 13/07/2021 | TAVAFLOX | LEVOFLOXACINE | 500 mg | CP | B/10 | TERIAK-TUNISIE | Extension des Indications |
19 | 13/07/2021 | TAVAFLOX | LEVOFLOXACINE | 500 mg | CP | B/05 | TERIAK-TUNISIE | Extension des Indications |
20 | 16/07/2021 | SIFLOKS | Ciprofloxacine | CP | B/28 | TERIAK-TUNISIE | indications | |
21 | 10/09/2021 | AMOXIL | amoxicilline | 1 GR | PPINJ | B/1FL+S EPPI/5ML | UNIMED-Tunisie | Extension des Indications |
22 | 10/09/2021 | AMOXIL | amoxicilline | 0.5 GR | PPINJ | B/1FL+S AB/5ML | UNIMED-Tunisie | Extension des Indications |
23 | 14/09/2021 | CEFTAZIM | Ceftazidime | 2 G | IV +Set de Transfert | B/1FL/20ml | UNIMED-Tunisie | Extension des Indications |
24 | 14/09/2021 | CEFTAZIM | ceftazidime | 1G | PPINJ IV IM | B/1FL | UNIMED-Tunisie | Extension des Indications |
25 | 14/09/2021 | CEFTAZIM | ceftazidime | 0.5 G | PPINJ IV IM | B/1FL/Solvant | UNIMED-Tunisie | Extension des Indications |
26 | 26/10/2021 | Tardipen | benzathine benzylpenicilline | 0.6 MUI | PPINJ | B/1FL/+Solvant | UNIMED-Tunisie | Extension des Indications |
27 | 26/10/2021 | Tardipen | benzathine benzylpenicilline | 1,2 MUI | PPINJ | B/25FL/+Solvant | UNIMED-Tunisie | Extension des Indications |
28 | 26/10/2021 | Tardipen | benzathine benzylpenicilline | 1,2 MUI | PPINJ | B/01FL/+Solvant | UNIMED-Tunisie | Extension des Indications |
29 | 03/11/2021 | AVALTEX | ACICLOVIR | 400 MG | Comprimé | B/30 | TAHA PHARMA-TUNISIE | AMM |
30 | 16/11/2021 | Ofloject | ofloxacine | 200/40 ML | SOL INJ | P/40 ML | UNIMED-Tunisie | Extension des Indications |
31 | 16/11/2021 | Ofloject | ofloxacine | 200/40 ML | SOL INJ | FL/40 ML | UNIMED-Tunisie | Extension des Indications |
32 | 16/11/2021 | Ofloject | ofloxacine | 200/40 ML | SOL INJ | B/10P/40 ML | UNIMED-Tunisie | Extension des Indications |
33 | 10/12/2021 | VERORAB | Vaccin antirabique | Suspension injectable | B/1FL | SANOFI PASTEUR SA | AMM | |
34 | 14/12/2021 | LOVIK | LEVOFLOXACINE | 500 mg | CP | B/10 | PHILADELPHIA-Tunisie | Extension des Indications |
35 | 14/12/2021 | LOVIK | LEVOFLOXACINE | 500 mg | CP | B/05 | PHILADELPHIA-Tunisie | Extension des Indications |
36 | 14/01/2022 | Zitro | AZITHROMYCINE | Lyophilisat pr sol pr perf | B/1 | Medis | AMM | |
37 | 18/01/2022 | Zitro | AZITHROMYCINE | 500 MG | Lyophilisat pr sol pr perf | B/10 | Medis-TUNISIE | AMM |
38 | 18/01/2022 | Zitro | AZITHROMYCINE | 500 MG | Lyophilisat pr sol pr perf | B/1 | Medis-TUNISIE | AMM |
39 | févr-22 | ZAVICEFTA | CEFTAZidime+AVIBACTAM | 2G/0.5G | PPINJ | Extension des Indications | ||
40 | 17/02/2022 | Ciproject | Ciprofloxacine | 200 mg/100 ml | SOL INJ | P pvc/100 ml | UNIMED-Tunisie | Extension des Indications |
41 | 17/02/2022 | Ciproject | Ciprofloxacine | 400 mg/100 ml | SOL INJ | P/200 ml | UNIMED-Tunisie | Extension des Indications |
42 | 17/02/2022 | Ciproject | Ciprofloxacine | 200 mg/100 ml | SOL INJ | P en mc/100 ml | UNIMED-Tunisie | Extension des Indications |
43 | 21/04/2022 | ABHAY-RAB | VACCIN ANTIRABIQUE | LYOPHILISAT P SOL INJ | B/1Fl | HUMAN BILOGICALS INSTITUTE INDE | AMM | |
44 | 16/11/2022 | OMNICEF | CEFDINIR | 250MG/5ML | MEDICEF TUNISIE | AMM | ||
45 | 16/11/2022 | OMNICEF | CEFDINIR | 300 MG | MEDICEF TUNISIE | AMM | ||
46 | 13/05/2022 | BACTRIM | COTRIMOXAZOLE | 400 mg/80 mg | B/20 | TERIAK-TUNISIE | Extension des Indications | |
47 | 16/05/2022 | BACTRIM FORTE | COTRIMOXAZOLE | 800 mg/160 mg | cp | B/10 | TERIAK-TUNISIE | Extension des Indications |
48 | 16/05/2022 | BACTRIM NRS/EFTS | COTRIMOXAZOLE | 200mg/40 mg | Suspension Buv | FL/100 ML | TERIAK-TUNISIE | Extension des Indications |
49 | 07/12/2022 | CYMEVIR | GANCICLOVIR | 500G | B/1 | MEDIS TUNISIE | AMM | |
50 | 07/12/2022 | Cyvaltex | valaciclovir | 300 MG | comprimé | b/30 | Taha Pahrma | AMM |
51 | 08/11/2022 | ELOVAC B Heoatitis B Vaccine I | VACCIN CONTRE L'HEPATITE B | Suspension injectable | B/10 | HUMAN BILOGICALS INSTITUTE INDE | AMM | |
52 | 23/11/2022 | LEVOX | LEVOFLOXACINE | 500 mg | CP | B/10 | ADWYA-Tunisie | Extension des Indications |
53 | 23/11/2022 | LEVOX | LEVOFLOXACINE | 500 mg | CP | B/05 | ADWYA-Tunisie | Extension des Indications |
54 | 23/11/2022 | NOVACLAV | AMOXICILLINE+ACIDE CLAVULANIQUE | 500mg/62.5 mg | Cp Pell | B/42 | ADWYA-Tunisie | AMM |
55 | 30/11/2022 | TAVACET | LEVOFLOXACINE | 5 mg/ml | SOL INJ | B/6FL/100 ML | DORCAS-Tunisie | Extension des Indications |
56 | 30/11/2022 | TAVACET | LEVOFLOXACINE | 5 mg/ml | SOL INJ | B/1FL/100 ML | DORCAS-Tunisie | Extension des Indications |
57 | 07/12/2022 | CIFLOXET | Ciprofloxacine | 200 mg/100 ml | SOL INJ | B/6FL/100 ML | DORCAS-Tunisie | Extension des Indications |
58 | 07/12/2022 | CIFLOXET | Ciprofloxacine | 200 mg/100 ml | SOL INJ | B/1FL/100 ML | DORCAS-Tunisie | Extension des Indications |
59 | 21/12/2022 | NOVAMOX | AMOXICILLINE+ACIDE CLAVULANIQUE | 1 Gr | Cp Dispersible | B/21 cp | ADWYA-Tunisie | AMM |
60 | 25/01/2023 | Ciprosaiph | Ciprofloxacine | 500 mg | cp | B/14 | SAIPH-TUNISIE | Extension des Indications |
61 | 22/02/2023 | ZERBAXA | CEFTOLOZANE+TAZOBACTAM | 1G/.5 GR | INJ | B/10 | MSD | INDICATIONS |
62 | 23/02/2023 | MENQUADFI | VACCIN ANTIMENINGOCOCCIQUE | PPINJ | B/1FL | SANOFI PASTEUR SA | AMM | |
63 | 00/01/1900 | COLIXIN | COLISTIN | 1000000 | Poudre pour solution injectable ou pour inhalation par nébuliseur | B/30 | Pharmis Biofamaceutica,Lda | AMM |
64 | 27/03/2023 | INFANRIX HEXA | VACCIN D+T+C+P+HB+HIB | Pdre p.prep.injectable | B/1fl+ser/0.5ml dose | Glaxo Smith KLine Biologicals | Extension des Indications | |
65 | 06/06/2023 | ZITHROCARE | AZITHROMYCINE | 500 MG | Comprimé pelliculé | B/3 | PHARMACARE-TUNISIE | Extension des Indications |
66 | 15/06/2023 | ADYFLU | OSELTAMIVIR | 75 MG | Gélule | B/10 | ADWYA-Tunisie | Extension des Indications |
67 | 28/08/2023 | PENI-V | PHENOXYMETHYLPENICILLINE | Comprimé pelliculé sécable | B/12 | SAIPH-TUNISIE | Extension des Indications |